PO-1297 Safety & feasibility of SIB in extreme 1-week hypofractionated radiotherapy for early breast cancer

Autor: Garcia Zanoguera, C., Gadea Quinteiro, J., Curbelo Artiles, A.G., Mateu Castell, L., Ortiz Gonzalez, I., Pardo Masferrer, J.
Zdroj: In Radiotherapy and Oncology May 2023 182 Supplement 1:S1040-S1040
Databáze: ScienceDirect